1. Home
  2. NX vs CTMX Comparison

NX vs CTMX Comparison

Compare NX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NX
  • CTMX
  • Stock Information
  • Founded
  • NX 1927
  • CTMX 2008
  • Country
  • NX United States
  • CTMX United States
  • Employees
  • NX N/A
  • CTMX N/A
  • Industry
  • NX Metal Fabrications
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NX Industrials
  • CTMX Health Care
  • Exchange
  • NX Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • NX 660.6M
  • CTMX 596.2M
  • IPO Year
  • NX N/A
  • CTMX 2015
  • Fundamental
  • Price
  • NX $13.38
  • CTMX $4.21
  • Analyst Decision
  • NX
  • CTMX Strong Buy
  • Analyst Count
  • NX 0
  • CTMX 5
  • Target Price
  • NX N/A
  • CTMX $5.80
  • AVG Volume (30 Days)
  • NX 554.0K
  • CTMX 3.3M
  • Earning Date
  • NX 12-11-2025
  • CTMX 11-06-2025
  • Dividend Yield
  • NX 2.39%
  • CTMX N/A
  • EPS Growth
  • NX N/A
  • CTMX 263.20
  • EPS
  • NX N/A
  • CTMX 0.49
  • Revenue
  • NX $1,839,956,000.00
  • CTMX $141,100,000.00
  • Revenue This Year
  • NX $46.73
  • CTMX N/A
  • Revenue Next Year
  • NX $0.48
  • CTMX N/A
  • P/E Ratio
  • NX N/A
  • CTMX $8.61
  • Revenue Growth
  • NX 70.18
  • CTMX 18.01
  • 52 Week Low
  • NX $13.01
  • CTMX $0.40
  • 52 Week High
  • NX $32.23
  • CTMX $4.46
  • Technical
  • Relative Strength Index (RSI)
  • NX 34.73
  • CTMX 73.96
  • Support Level
  • NX $13.99
  • CTMX $3.22
  • Resistance Level
  • NX $15.83
  • CTMX $3.50
  • Average True Range (ATR)
  • NX 0.53
  • CTMX 0.31
  • MACD
  • NX -0.06
  • CTMX 0.05
  • Stochastic Oscillator
  • NX 13.12
  • CTMX 80.93

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: